Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BCAS1 resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Additionally we are shipping BCAS1 Proteins (14) and many more products for this protein.
Showing 10 out of 75 products:
Human Monoclonal BCAS1 Primary Antibody for IHC (p), ELISA - ABIN394844
Rose, Behm, Drgon, Johnson, Uhl: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. in Molecular medicine (Cambridge, Mass.) 2010
Show all 5 references for 394844
Two transcripts with regulation from days 7 to 28 in the 1-methyl-4-phenyl-tetrahydropyridine treated groups, are identified: brain specific (show CALY Antibodies) angiogenesis inhibitor associated protein 3 (show HSPB3 Antibodies) (Baiap3 (show BAIAP3 Antibodies)) and breast carcinoma amplified sequence 1 (Bcas1).
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.
breast carcinoma amplified sequence 1
, breast carcinoma-amplified sequence 1-like
, amplified and overexpressed in breast cancer
, breast carcinoma-amplified sequence 1
, novel amplified in breast cancer 1
, amplified in breast cancer 1
, breast carcinoma-amplified sequence 1 homolog
, novel amplified in breast cancer 1 homolog
, band 83